Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone (Q44062283)

29 November 2017

title

Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone (English)

1 reference

29 November 2017

0 references

Robert Bennett

4

0 references

author name string

Eduardo S Paiva

series ordinal

1

1 reference

29 November 2017

Atul Deodhar

series ordinal

2

1 reference

29 November 2017

Kim D Jones

series ordinal

3

1 reference

29 November 2017

publication date

1 May 2002

1 reference

29 November 2017

published in

Arthritis & Rheumatology

1 reference

29 November 2017

volume

46

1 reference

29 November 2017

issue

5

1 reference

29 November 2017

page(s)

1344-1350

1 reference

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

29 November 2017

cites work

1 reference

Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia

21 January 2018

1 reference

Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain

21 January 2018

1 reference

Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones

21 January 2018

1 reference

Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome

21 January 2018

1 reference

Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia

21 January 2018

1 reference

The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.

21 January 2018

1 reference

The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man.

21 January 2018

1 reference

GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.

21 January 2018

1 reference

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone

21 January 2018

1 reference

Hormonal pertubations in fibromyalgia syndrome

21 January 2018

1 reference

Neurohormonal perturbations in fibromyalgia

21 January 2018

1 reference

Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia

21 January 2018

1 reference

Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome

21 January 2018

1 reference

A syndrome produced by diverse nocuous agents. 1936.

21 January 2018

1 reference

Involvement of hypothalamic somatostatin in the suppression of growth hormone secretion by central corticotropin-releasing factor in conscious male rats

21 January 2018

1 reference

Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat.

21 January 2018

1 reference

Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity?

21 January 2018

1 reference

21 January 2018

1 reference

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

21 January 2018

1 reference

Psychological and endocrine correlates of chronic pelvic pain associated with adhesions

21 January 2018

1 reference

Adaptation of the hypothalamopituitary adrenal axis to chronic exercise stress in humans

21 January 2018

1 reference

Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study

21 January 2018

1 reference

Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms

21 January 2018

1 reference

Neuroendocrine deficiency-mediated development and persistence of pain in fibromyalgia: a promising paradigm?

21 January 2018

1 reference

21 January 2018

1 reference

The neurobiology of stress: understanding regulation of affect during female biological transitions

21 January 2018

1 reference

The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.10209

1 reference

29 November 2017

1 reference